| Sorafenib in advanced hepatocellular carcinoma JM Llovet, S Ricci, V Mazzaferro, P Hilgard, E Gane, JF Blanc, ... New England journal of medicine 359 (4), 378-390, 2008 | 15412 | 2008 |
| Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials C Camma, F Schepis, A Orlando, M Albanese, L Shahied, F Trevisani, ... Radiology 224 (1), 47-54, 2002 | 1079 | 2002 |
| Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status F Trevisani, PE D'Intino, AM Morselli-Labate, G Mazzella, E Accogli, ... Journal of hepatology 34 (4), 570-575, 2001 | 905 | 2001 |
| Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma R Golfieri, E Giampalma, M Renzulli, R Cioni, I Bargellini, C Bartolozzi, ... British journal of cancer 111 (2), 255-264, 2014 | 641 | 2014 |
| Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma: both or neither? F Farinati, D Marino, M De Giorgio, A Baldan, M Cantarini, C Cursaro, ... Official journal of the American College of Gastroenterology| ACG 101 (3 …, 2006 | 548 | 2006 |
| Q‐T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors M Bernardi, S Calandra, A Colantoni, F Trevisani, ML Raimondo, G Sica, ... Hepatology 27 (1), 28-34, 1998 | 508 | 1998 |
| Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria M Ravaioli, GL Grazi, F Piscaglia, F Trevisani, M Cescon, G Ercolani, ... American Journal of Transplantation 8 (12), 2547-2557, 2008 | 442 | 2008 |
| Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression M Trudu, S Janas, C Lanzani, H Debaix, C Schaeffer, M Ikehata, L Citterio, ... Nature medicine 19 (12), 1655-1660, 2013 | 372 | 2013 |
| Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience) F Trevisani, S De Notariis, G Rapaccini, F Farinati, L Benvegnu, M Zoli, ... Official journal of the American College of Gastroenterology| ACG 97 (3 …, 2002 | 361 | 2002 |
| Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival V Santi, F Trevisani, A Gramenzi, A Grignaschi, F Mirici-Cappa, ... Journal of hepatology 53 (2), 291-297, 2010 | 357 | 2010 |
| Prognosis of untreated hepatocellular carcinoma EG Giannini, F Farinati, F Ciccarese, A Pecorelli, GL Rapaccini, ... Hepatology 61 (1), 184-190, 2015 | 282 | 2015 |
| Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal F Trevisani, M Frigerio, V Santi, A Grignaschi, M Bernardi Digestive and Liver Disease 42 (5), 341-347, 2010 | 242 | 2010 |
| Cardiac electrophysiological abnormalities in patients with cirrhosis A Zambruni, F Trevisani, P Caraceni, M Bernardi Journal of hepatology 44 (5), 994-1002, 2006 | 237 | 2006 |
| Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis R Golfieri, M Renzulli, V Lucidi, B Corcioni, F Trevisani, L Bolondi European Radiology 21, 1233-1242, 2011 | 234 | 2011 |
| Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ... Journal of hepatology 62 (3), 617-624, 2015 | 230 | 2015 |
| Longitudinal liquid biopsy and mathematical modeling of clonal evolution forecast time to treatment failure in the PROSPECT-C phase II colorectal cancer clinical trial KH Khan, D Cunningham, B Werner, G Vlachogiannis, I Spiteri, T Heide, ... Cancer discovery 8 (10), 1270-1285, 2018 | 229 | 2018 |
| Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status G Vendemiale, I Grattagliano, P Caraceni, G Caraccio, M Domenicali, ... Hepatology 33 (4), 808-815, 2001 | 219 | 2001 |
| Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patient F Trevisani, PE D'Intino, P Caraceni, M Pizzo, GF Stefanini, A Mazziotti, ... Cancer 75 (9), 2220-2232, 1995 | 216 | 1995 |
| Recent advances in the natural history of hepatocellular carcinoma F Trevisani, MC Cantarini, JR Wands, M Bernardi Carcinogenesis 29 (7), 1299-1305, 2008 | 214 | 2008 |
| Aspartyl‐asparagyl β hydroxylase over‐expression in human hepatoma is linked to activation of insulin‐like growth factor and notch signaling mechanisms MC Cantarini, SM de la Monte, M Pang, M Tong, A D'Errico, F Trevisani, ... Hepatology 44 (2), 446-457, 2006 | 206 | 2006 |
